Caris Life Sciences, Inc. Common Stock (CAI) — Working Capital to Net Assets Ratio
Caris Life Sciences, Inc. Common Stock (CAI) has a Working Capital to Net Assets ratio of 146.6% as of March 2026. Working capital of $870.28 Million (current assets of $1.01 Billion minus current liabilities of $143.90 Million) is measured against net assets of $593.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CAI equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Caris Life Sciences, Inc. Common Stock Working Capital to Net Assets (2005–2025)
This chart shows how Caris Life Sciences, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 146.6%, reflecting working capital of $870.28 Million against net assets of $593.49 Million USD. Check Caris Life Sciences, Inc. Common Stock (CAI) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Caris Life Sciences, Inc. Common Stock (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Caris Life Sciences, Inc. Common Stock from 2005 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Caris Life Sciences, Inc. Common Stock.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 150.8% | $870.65 Million | $577.31 Million | $997.80 Million | $127.14 Million | ▲ +152.8 pp |
| 2024 | -2.0% | $50.31 Million | $-2.50 Billion | $215.73 Million | $165.42 Million | ▲ +4.9 pp |
| 2023 | -6.9% | $147.47 Million | $-2.14 Billion | $242.61 Million | $95.14 Million | ▲ +15.4 pp |
| 2022 | -22.3% | $379.14 Million | $-1.70 Billion | $516.04 Million | $136.91 Million | ▼ -7.2 pp |
| 2020 | -15.0% | $-105.59 Million | $702.24 Million | $214.66 Million | $320.25 Million | ▼ -45.6 pp |
| 2019 | 30.5% | $211.72 Million | $693.24 Million | $499.13 Million | $287.41 Million | ▲ +59.9 pp |
| 2018 | -29.3% | $-205.51 Million | $701.13 Million | $220.02 Million | $425.53 Million | ▼ -8.1 pp |
| 2017 | -21.2% | $-119.59 Million | $563.85 Million | $140.34 Million | $259.93 Million | ▼ -14.9 pp |
| 2016 | -6.3% | $-28.85 Million | $457.50 Million | $135.15 Million | $164.01 Million | ▲ +9.7 pp |
| 2015 | -16.0% | $-73.77 Million | $461.26 Million | $144.11 Million | $217.88 Million | ▲ +7.6 pp |
| 2014 | -23.6% | $-104.39 Million | $442.90 Million | $144.80 Million | $249.19 Million | ▼ -17.3 pp |
| 2013 | -6.3% | $-25.98 Million | $415.13 Million | $130.97 Million | $156.94 Million | ▼ -2.9 pp |
| 2012 | -3.4% | $-11.66 Million | $346.85 Million | $95.11 Million | $106.78 Million | ▼ -1.7 pp |
| 2011 | -1.7% | $-4.15 Million | $248.74 Million | $74.90 Million | $79.05 Million | ▲ +41.6 pp |
| 2010 | -43.3% | $-85.51 Million | $197.67 Million | $68.65 Million | $154.16 Million | ▼ -62.6 pp |
| 2009 | 19.3% | $24.93 Million | $129.10 Million | $63.38 Million | $38.45 Million | ▼ -12.1 pp |
| 2008 | 31.4% | $35.75 Million | $113.79 Million | $80.99 Million | $45.24 Million | ▲ +33.9 pp |
| 2007 | -2.4% | $-3.20 Million | $131.15 Million | $53.43 Million | $56.63 Million | ▲ +62.6 pp |
| 2006 | -65.0% | $-18.05 Million | $27.75 Million | $59.52 Million | $77.56 Million | ▼ -54.2 pp |
| 2005 | -10.8% | $-3.58 Million | $32.99 Million | $41.40 Million | $44.97 Million | — |